These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 25092654)

  • 21. Demyelination in multiple sclerosis.
    Lubetzki C; Stankoff B
    Handb Clin Neurol; 2014; 122():89-99. PubMed ID: 24507514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA; Akirav EM
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological aspects of axon injury in multiple sclerosis.
    Howe CL
    Curr Top Microbiol Immunol; 2008; 318():93-131. PubMed ID: 18219816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. White matter involvement after TBI: Clues to axon and myelin repair capacity.
    Armstrong RC; Mierzwa AJ; Marion CM; Sullivan GM
    Exp Neurol; 2016 Jan; 275 Pt 3():328-333. PubMed ID: 25697845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
    Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
    Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Collateral bystander damage by myelin-directed CD8+ T cells causes axonal loss.
    Sobottka B; Harrer MD; Ziegler U; Fischer K; Wiendl H; Hünig T; Becher B; Goebels N
    Am J Pathol; 2009 Sep; 175(3):1160-6. PubMed ID: 19700745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination.
    Harrington EP; Zhao C; Fancy SP; Kaing S; Franklin RJ; Rowitch DH
    Ann Neurol; 2010 Nov; 68(5):703-16. PubMed ID: 20853437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Axonal damage in multiple sclerosis: a complex issue in a complex disease.
    Grigoriadis N; Ben-Hur T; Karussis D; Milonas I
    Clin Neurol Neurosurg; 2004 Jun; 106(3):211-7. PubMed ID: 15177770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of damage to myelin and oligodendrocytes and their relevance to disease.
    Merrill JE; Scolding NJ
    Neuropathol Appl Neurobiol; 1999 Dec; 25(6):435-58. PubMed ID: 10632895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple sclerosis - candidate mechanisms underlying CNS atrophy.
    Siffrin V; Vogt J; Radbruch H; Nitsch R; Zipp F
    Trends Neurosci; 2010 Apr; 33(4):202-10. PubMed ID: 20153532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity-Dependent and Experience-Driven Myelination Provide New Directions for the Management of Multiple Sclerosis.
    Jensen SK; Yong VW
    Trends Neurosci; 2016 Jun; 39(6):356-365. PubMed ID: 27113322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remyelination protects axons from demyelination-associated axon degeneration.
    Irvine KA; Blakemore WF
    Brain; 2008 Jun; 131(Pt 6):1464-77. PubMed ID: 18490361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoting myelin repair and return of function in multiple sclerosis.
    Zhang J; Kramer EG; Asp L; Dutta DJ; Navrazhina K; Pham T; Mariani JN; Argaw AT; Melendez-Vasquez CV; John GR
    FEBS Lett; 2011 Dec; 585(23):3813-20. PubMed ID: 21864535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
    Stoffels JM; de Jonge JC; Stancic M; Nomden A; van Strien ME; Ma D; Sisková Z; Maier O; Ffrench-Constant C; Franklin RJ; Hoekstra D; Zhao C; Baron W
    Brain; 2013 Jan; 136(Pt 1):116-31. PubMed ID: 23365094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aging-Exacerbated Acute Axon and Myelin Injury Is Associated with Microglia-Derived Reactive Oxygen Species and Is Alleviated by the Generic Medication Indapamide.
    Michaels NJ; Lemmon K; Plemel JR; Jensen SK; Mishra MK; Brown D; Rawji KS; Koch M; Yong VW
    J Neurosci; 2020 Oct; 40(44):8587-8600. PubMed ID: 33060175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes of statistical structural fluctuations unveils an early compacted degraded stage of PNS myelin.
    Poccia N; Campi G; Ricci A; Caporale AS; Di Cola E; Hawkins TA; Bianconi A
    Sci Rep; 2014 Jun; 4():5430. PubMed ID: 24962806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inherited and acquired disorders of myelin: The underlying myelin pathology.
    Duncan ID; Radcliff AB
    Exp Neurol; 2016 Sep; 283(Pt B):452-75. PubMed ID: 27068622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myelin repair strategies: a cellular view.
    Gallo V; Armstrong RC
    Curr Opin Neurol; 2008 Jun; 21(3):278-83. PubMed ID: 18451710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cells of the oligodendroglial lineage, myelination, and remyelination.
    Miron VE; Kuhlmann T; Antel JP
    Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Axonal activity-dependent myelination in development: Insights for myelin repair.
    Mitew S; Xing YL; Merson TD
    J Chem Neuroanat; 2016 Oct; 76(Pt A):2-8. PubMed ID: 26968658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.